Kezar Life Sciences Inc KZR
$7.29 $0.07 (0.95%) 1D
Last Updated: May 08, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
KZR Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Kezar Life Sciences Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Kezar Life Sciences Inc. Stock Analysis KZR
United States Health Care Micro Cap Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. The company is headquartered in South San Francisco, California and currently employs 9 full-time employees. The company went IPO on 2018-06-21. The firm's lead product candidate, zetomipzomib, is a first-in-class selective immunoproteasome inhibitor that has completed Phase Ia testing in healthy volunteers and a Phase Ib/IIa clinical trial in patients with systemic lupus erythematosus (SLE), with or without lupus nephritis (LN). The firm is focused on the development of zetomipzomib in autoimmune hepatitis, or AIH, a rare, chronic disease in which the immune system attacks the liver and causes inflammation and tissue damage. Its PORTOLA is a placebo-controlled, double-blind Phase IIa clinical trial of zetomipzomib in patients with AIH that were insufficiently responding to standard of care or have relapsed.
Kezar Life Sciences Inc (KZR) Chart
Financial Metrics & Statements of Kezar Life Sciences Inc (KZR)
FAQ's for Kezar Life Sciences Inc (KZR)
- As of August 2026, Kezar Life Sciences Inc KZR is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Kezar Life Sciences Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Kezar Life Sciences Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Kezar Life Sciences Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Kezar Life Sciences Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Kezar Life Sciences Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Kezar Life Sciences Inc (KZR)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
